NEOGENOMICS INC
- CIK: 0001077183
- EIN: 74-2897368
- Business address: 9490 NEOGENOMICS WAY, FORT MYERS, Florida, 33912
About NEOGENOMICS INC
NEOGENOMICS INC (CIK: 0001077183) is an American company incorporated in the state of Florida. Head office is located at 9490 NEOGENOMICS WAY, FORT MYERS, Florida, 33912. Work in the industry 8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES. NEOGENOMICS INC is a public company and trade via Over-The-Counter (OTC).Old names:
- AMERICAN COMMUNICATIONS ENTERPRISES INC from 1999-08-Apr to 2002-05-Feb
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Zook Anthony P. | 0001582393 | Jun-26-2023 | director |
| Floegel Elizabeth | 0001984128 | Jun-26-2023 | director |
| Gunn Neil | 0001984436 | Jun-26-2023 | director |
| Aunan Greg D | 0001646370 | May-15-2023 | officer: Chief Accounting Officer |
| Sherman Jeffrey Scott | 0001463145 | Dec-05-2022 | officer: Chief Financial Officer |
| Harris Melody | 0001880847 | Dec-05-2022 | officer: President, Enterprise Ops |
| Stone Warren | 0001955295 | Nov-21-2022 | officer: President, Clinical Services |
| Perez David Brian | 0001765355 | Nov-03-2022 | director |
| Olivo Alicia C | 0001951869 | Oct-18-2022 | officer: General Counsel |
| Smith Christopher M | 0001436707 | Aug-15-2022 | officer: Chief Executive Officer |
| Kulkarni Shashikant | 0001936800 | Jul-07-2022 | officer: President of Lab Operations |
| Sikri Vishal | 0001931406 | May-23-2022 | officer: President and CCO, Inivata |
| Sholehvar David | 0001916426 | Apr-01-2022 | officer: President, Clinical Services |
| Daly David | 0001320267 | Nov-10-2021 | director |
| Gilbert Halley E | 0001601360 | Aug-17-2021 | officer: Chief Legal Officer |
| Wallar Gina M | 0001869819 | Jul-05-2021 | officer: President, Pharma Services |
| Morris Clive | 0001869893 | Jun-18-2021 | officer: President of Inivata |
| Mallon Mark | 0001763533 | Apr-19-2021 | director, officer: Chief Executive Officer |
| Brown Douglas Matthew | 0001849414 | Feb-23-2021 | officer: Chief Strategy Officer |
| Kelly Michael Aaron | 0001769668 | Jul-15-2020 | director |
| Dieter Cynthia J | 0001815335 | Jun-22-2020 | officer: Chief Accounting Officer |
| Stahler Rachel A | 0001679854 | May-28-2020 | director |
| Pedulla Denise E | 0001804602 | Feb-19-2020 | officer: General Counsel |
| KANOVSKY STEPHEN M | 0001713090 | Jun-06-2019 | director |
| Virag Sharon | 0001576811 | Mar-01-2019 | officer: Chief Financial Officer |
| McKenzie Kathryn B | 0001720001 | Mar-01-2019 | officer: Principal Accounting Officer |
| Weiss Lawrence Martin | 0001761625 | Dec-12-2018 | officer: Chief Scientific Officer |
| BRODIE STEVEN G. | 0001640522 | Oct-22-2018 | officer: VP - Pharma Operations |
| HIPP RAYMOND R | 0001188214 | Jun-01-2018 | director |
| CROWTHER BRUCE K | 0001244274 | Jun-01-2018 | director |
| Johnson Kevin C | 0001353436 | Jun-01-2018 | director |
| TETRAULT LYNN A. | 0001645512 | Jun-01-2018 | director |
| HANNAH ALISON L. | 0001645600 | Jun-01-2018 | director |
| JONES STEVEN C | 0001518732 | May-29-2018 | director, officer: Executive Vice President |
| VAN OORT DOUGLAS M | 0001518733 | May-25-2018 | officer: Chairman and CEO |
| CARDOZA GEORGE | 0001518734 | May-25-2018 | officer: President, Pharma Services |
| SHOVLIN ROBERT J. | 0001621453 | May-25-2018 | officer: President, Clinical Services |
| BALLIET JENNIFER | 0001640500 | May-25-2018 | officer: VP and Chief Culture Officer |
| ROSS STEVEN A | 0001591976 | May-10-2018 | officer: CIO |
| BYWATER STEPHANIE K | 0001739179 | May-01-2018 | officer: Chief Compliance Officer |
| Bonello William | 0001454941 | Apr-19-2018 | officer: VP, Investor Relations |
| Murphy Kieran Pius | 0001667685 | Feb-17-2016 | director |
| Machulcz Mark Alan | 0001664190 | Jan-28-2016 | officer: Vice President of Operations |
| GENERAL ELECTRIC CO | 0000040545 | Dec-30-2015 | 10 percent owner |
| GE Medical Systems Information Technologies, Inc. | 0001662667 | Dec-30-2015 | 10 percent owner |
| HOREL ROBERT H. | 0001627350 | Dec-18-2014 | officer: Vice President andGM PathLogic |
| ALBITAR MAHER | 0001591950 | Feb-21-2013 | officer: Chief Medical Officer |
| CLEARMAN STEPHEN J | 0001032874 | May-14-2012 | 10 percent owner |
| KINDERHOOK PARTNERS, LP | 0001220338 | May-14-2012 | 10 percent owner |
| KINDERHOOK GP LLC | 0001266402 | May-14-2012 | 10 percent owner |
| Shah Tushar | 0001487632 | May-14-2012 | 10 percent owner |
| KINDERHOOK CAPITAL MANAGEMENT, LLC | 0001542439 | May-14-2012 | 10 percent owner |
| PETERSON PETER M | 0001260044 | May-02-2011 | director, 10 percent owner |
| Robison William J | 0001372151 | May-02-2011 | director |
| GASPARINI ROBERT P | 0001518647 | May-02-2011 | director, officer: Chief Scientific Officer |
| SMITS MARK W | 0001518730 | May-02-2011 | officer: Chief Commercial Officer |
| MILLER MARYDAWN | 0001518731 | May-02-2011 | officer: Vice President of IT |
| DVONCH JEROME J | 0001518735 | May-02-2011 | officer: Prinicpal Accounting Officer |
| DENT MICHAEL T | 0001518888 | May-02-2011 | director |
| ASPEN SELECT HEALTHCARE LP | 0001519599 | May-02-2011 | 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NEOGENOMICS INC
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| ARS | Document | Annual report to security holders Acc-no: 0001077183-25-000069 (34 Act) Size: KB |
Apr-08-2025 | 25822083 |
| DEF 14A | Document | Definitive proxy statements Acc-no: 0001077183-25-000068 (34 Act) Size: KB |
Apr-08-2025 | 25822057 |
| 8-K | Document | Current report filing Acc-no: 0001077183-25-000067 (34 Act) Size: KB |
Apr-08-2025 | 25821993 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000059 ( Act) Size: 0 KB |
Apr-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000058 ( Act) Size: 0 KB |
Apr-03-2025 | |
| 8-K/A | Document | Amendment to Current report filing Acc-no: 0001077183-25-000055 (34 Act) Size: KB |
Mar-31-2025 | 25793221 |
| 8-K/A | Document | Amendment to Current report filing Acc-no: 0001077183-25-000052 (34 Act) Size: KB |
Mar-19-2025 | 25752777 |
| 8-K | Document | Current report filing Acc-no: 0001077183-25-000048 (34 Act) Size: KB |
Mar-18-2025 | 25749779 |
| SCHEDULE 13G | Document | Acc-no: 0001104659-25-024995 (34 Act) Size: KB | Mar-18-2025 | 25748093 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000044 ( Act) Size: 0 KB |
Feb-25-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000043 ( Act) Size: 0 KB |
Feb-25-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000042 ( Act) Size: 0 KB |
Feb-25-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000041 ( Act) Size: 0 KB |
Feb-25-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000040 ( Act) Size: 0 KB |
Feb-25-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000039 ( Act) Size: 0 KB |
Feb-25-2025 | |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001077183-25-000028 (34 Act) Size: KB |
Feb-18-2025 | 25635100 |
| 8-K | Document | Current report filing Acc-no: 0001077183-25-000024 (34 Act) Size: KB |
Feb-18-2025 | 25632720 |
| SCHEDULE 13G/A | Document | Acc-no: 0001274173-25-000046 (34 Act) Size: KB | Feb-14-2025 | 25625169 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000020 ( Act) Size: 0 KB |
Jan-16-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001077183-25-000018 ( Act) Size: 0 KB |
Jan-16-2025 |
Recent 20 filings. View all NEOGENOMICS INC filings
Reviews
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Catherine
Thanks I look forward to using the product to improve my skin tone
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Frequently Asked Questions
Tags:
- NEOGENOMICS INC overview
- NEOGENOMICS INC job
- NEOGENOMICS INC stock
- NEOGENOMICS INC ownership
- NEOGENOMICS INC CEO
- NEOGENOMICS INC documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
UL Solutions Inc.
Update: Nov 14, 2023
Wavemaker Labs Asia Inc.
Update: Aug 25, 2022
VICAR OPERATING INC
Update: Aug 24, 2022
U S LABORATORIES INC
Update: Aug 24, 2022
THERMO TERRATECH INC
Update: Aug 23, 2022
RESPONSE BIOMEDICAL CORP
Update: Aug 20, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 